Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.

RATIONALE Lower limb muscle dysfunction contributes to exercise intolerance in chronic obstructive pulmonary disease (COPD). We hypothesized that signaling from lower limb muscle group III/IV sensory afferents to the central motor command could be involved in premature cycling exercise termination in COPD. OBJECTIVES To evaluate the effects of spinal anesthesia, which presumably inhibited central feedback from the lower limb muscle group III/IV sensory afferents on exercise tolerance and cardiorespiratory response during constant work-rate cycling exercise in patients with COPD. METHODS In a crossover and double-blind randomized design, eight patients with COPD (FEV(1), 67 ± 8% predicted) completed a constant work-rate cycling exercise after sham (NaCl, interspinous L(3)-L(4)) or active (fentanyl 25 μg, intrathecal L(3)-L(4)) spinal anesthesia. MEASUREMENTS AND MAIN RESULTS When compared with placebo, endurance time was significantly prolonged after spinal anesthesia with fentanyl (639 ± 87 s vs. 423 ± 38 s [mean ± SEM]; P = 0.01). Ventilation and respiratory rate were reduced at isotime points under the fentanyl condition, whereas ventilatory efficiency and dead space ventilation were improved. Patients exhibited less dynamic hyperinflation at isotime points with spinal anesthesia. Consequently, the rise in dyspnea was significantly flatter during the fentanyl condition than with placebo. CONCLUSIONS Spinal anesthesia enhanced cycling exercise tolerance in patients with COPD, mostly by reducing ventilatory response and dyspnea during exercise; these effects were possibly mediated through the inhibition of group III/IV lower limb sensory muscle afferents.

[1]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[2]  J. Mitchell,et al.  Neural control of cardiovascular responses and of ventilation during dynamic exercise in man. , 1993, The Journal of physiology.

[3]  F. Maltais,et al.  Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease. , 2011, Journal of applied physiology.

[4]  F. Maltais,et al.  Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. , 2005, Chest.

[5]  D. O’Donnell,et al.  Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. , 2006, Journal of applied physiology.

[6]  B. Make,et al.  Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.

[7]  M. White,et al.  Muscle afferent contributions to the cardiovascular response to isometric exercise , 2004, Experimental physiology.

[8]  M. Tsukino,et al.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.

[9]  S. Gandevia Spinal and supraspinal factors in human muscle fatigue. , 2001, Physiological reviews.

[10]  Markus Amann,et al.  Opioid‐mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans , 2009, The Journal of physiology.

[11]  Y. Honda,et al.  Afferent and cardiodynamic drives in the early phase of exercise hyperpnea in humans. , 1989, Journal of applied physiology.

[12]  J. Dempsey,et al.  Implications of group III and IV muscle afferents for high‐intensity endurance exercise performance in humans , 2011, The Journal of physiology.

[13]  M. Chaney Side effects of intrathecal and epidural opioids , 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[14]  F. Maltais,et al.  Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. , 1998, Journal of applied physiology.

[15]  D. O’Donnell,et al.  The major limitation to exercise performance in COPD is dynamic hyperinflation. , 2008, Journal of applied physiology.

[16]  M. Mador,et al.  Quadriceps Fatigue After Cycle Exercise in Patients with COPD Compared with Healthy Control Subjects. , 2003, Chest.

[17]  J. Barberà,et al.  Effects of Endurance Training on Skeletal Muscle Bioenergetics in Chronic Obstructive Pulmonary Disease , 1999 .

[18]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[19]  W Schaffartzik,et al.  Relationship between body and leg VO2 during maximal cycle ergometry. , 1992, Journal of applied physiology.

[20]  R. Casaburi,et al.  Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. , 2011, Respiratory medicine.

[21]  D. O’Donnell Ventilatory limitations in chronic obstructive pulmonary disease. , 2001, Medicine and science in sports and exercise.

[22]  Samuele M. Marcora Role of feedback from Group III and IV muscle afferents in perception of effort, muscle pain, and discomfort. , 2011, Journal of applied physiology.

[23]  S. Ward,et al.  Determinants and control of breathing during muscular exercise. , 1998, British journal of sports medicine.

[24]  M. Piepoli,et al.  Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. , 1996, Circulation.

[25]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[26]  D. Poole,et al.  Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[27]  P. Kadowitz,et al.  Influence of sympathetic stimulation and vasoactive substances on the canine pulmonary veins. , 1975, The Journal of clinical investigation.

[28]  Sergio Tufik,et al.  Afferent pain pathways: a neuroanatomical review , 2004, Brain Research.

[29]  D. Bates,et al.  Respiratory function in disease , 1989 .

[30]  Y. Lacasse,et al.  Assessing the impact of pulmonary rehabilitation on functional status in COPD , 2007, Thorax.

[31]  J. Dempsey,et al.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  C. Adreani,et al.  Responses of group III and IV muscle afferents to dynamic exercise. , 1997, Journal of applied physiology.

[33]  D. O’Donnell,et al.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[34]  J. Dempsey,et al.  Control of breathing during exercise. , 2012, Comprehensive Physiology.

[35]  A. Borghi-Silva,et al.  Respiratory muscle unloading improves leg muscle oxygenation during exercise in patients with COPD , 2008, Thorax.

[36]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[37]  J. Hughes,et al.  Inspiratory flow rate and ventilation distribution in normal subjects and in patients with simple chronic bronchitis. , 1972, Clinical science.

[38]  F. Maltais,et al.  Impact of preinduced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. , 2009, Journal of applied physiology.

[39]  F. Maltais,et al.  Effects of oxygen on lower limb blood flow and O2 uptake during exercise in COPD. , 2001, Medicine and science in sports and exercise.

[40]  J. Dempsey,et al.  Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans. , 2010, Journal of applied physiology.

[41]  H. Bell Respiratory control at exercise onset: An integrated systems perspective , 2006, Respiratory Physiology & Neurobiology.

[42]  D. Morin,et al.  Coordinations of Locomotor and Respiratory Rhythms In Vitro Are Critically Dependent on Hindlimb Sensory Inputs , 2002, The Journal of Neuroscience.

[43]  F. Maltais,et al.  Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[44]  M. Belman,et al.  Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. , 1991, The American review of respiratory disease.

[45]  M. Kaufman,et al.  Effect of metabolic products of muscular contraction on discharge of group III and IV afferents. , 1988, Journal of applied physiology.

[46]  F. Maltais,et al.  The major limitation to exercise performance in COPD is lower limb muscle dysfunction. , 2008, Journal of applied physiology.

[47]  D. Niv,et al.  Ventilatory effects of subarachnoid fentanyl in the elderly , 1990, Anaesthesia.